Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation

Journal of Pineal Research

Volumn 59, Issue 1, 2015, Pages 38-46

  Soliman, Ahmed ^a   Lacasse, Andrée Anne ^a   Lanoix, Dave ^a   Sagrillo Fagundes, Lucas ^a   Boulard, Véronique ^a   Vaillancourt, Cathy ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

arylalkylamine N acetyltransferase; HIOMT (ASMT); human chorionic gonadotropin; MT1 melatonin receptor; MT2 melatonin receptor; syncytiotrophoblast; villous cytotrophoblast

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; ARALKYLAMINE ACETYLTRANSFERASE; CHORIONIC GONADOTROPIN BETA SUBUNIT; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MESSENGER RNA; AANAT PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CHORION VILLUS; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; TROPHOBLAST; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM;

ACETYLSEROTONIN O-METHYLTRANSFERASE; ARYLALKYLAMINE N-ACETYLTRANSFERASE; CELL DIFFERENTIATION; CELLS, CULTURED; CHORIONIC VILLI; FEMALE; HUMANS; IN VITRO TECHNIQUES; MELATONIN; PREGNANCY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RNA, MESSENGER; TROPHOBLASTS;

EID: 84934298185     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12236     Document Type: Article

References (70)

1. Longtine MS, Nelson DM,. Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition. Semin Reprod Med 2011; 29: 187-196.
2. Rampersad RCZM, Nelson DM,. Development and anatomy of the human placenta. The Placenta: From Development to Disease 2011;: 19-26.
3. Malassine A,. Morphological variability and placental function. Gynecol Obstet Fertil 2001; 29: 489-496.
4. Aplin JD,. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 1991; 99 (Pt 4): 681-692.
5. Desforges M, Sibley CP,. Placental nutrient supply and fetal growth. Int J Dev Biol 2010; 54: 377-390.
6. Vaillancourt C, Lanoix D, le Bellego F, et al., Involvement of MAPK signalling in human villous trophoblast differentiation. Mini Rev Med Chem 2009; 9: 962-973.
7. Morrish DW, Bhardwaj D, Dabbagh LK, et al., Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab 1987; 65: 1282-1290.
8. Handschuh K, Guibourdenche J, Tsatsaris V, et al., Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. Placenta 2007; 28: 175-184.
9. Newbern D, Freemark M,. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18: 409-416.
10. Mounier C, Barbeau B, Vaillancourt C, et al., Endocrinology and cell signaling in human villous trophoblast. Methods Mol Biol 2009; 550: 89-102.
11. Kliman HJ, Nestler JE, Sermasi E, et al., Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118: 1567-1582.
12. Castellucci M, Scheper M, Scheffen I, et al., The development of the human placental villous tree. Anat Embryol (Berl) 1990; 181: 117-128.
13. Miller RK, Genbacev O, Turner MA, et al., Human placental explants in culture: approaches and assessments. Placenta 2005; 26: 439-448.
14. Ishihara N, Matsuo H, Murakoshi H, et al., Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186: 158-166.
15. Burton GJ, Jauniaux E,. Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011; 25: 287-299.
16. Lanoix D, Guerin P, Vaillancourt C,. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy. J Pineal Res 2012; 53: 417-425.
17. John R, Hemberger M,. A placenta for life. Reprod Biomed Online 2012; 25: 5-11.
18. Hardeland R, Pandi-Perumal SR, Cardinali DP,. Melatonin. Int J Biochem Cell Biol 2006; 38: 313-316.
19. Lanoix D, Beghdadi H, Lafond J, et al., Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008; 45: 50-60.
20. Bubenik GA,. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.
21. Slominski A, Tobin DJ, Zmijewski MA, et al., Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 2008; 19: 17-24.
22. Tosini G, Menaker M,. The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res 1998; 789: 221-228.
23. Zawilska JB, Skene DJ, Arendt J,. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61: 383-410.
24. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, et al., Melatonin: Nature's most versatile biological signal? FEBS J 2006; 273: 2813-2838.
25. Maronde E, Saade A, Ackermann K, et al., Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland. J Pineal Res 2011; 51: 145-155.
26. Wurtman RJ, Axelrod J,. The formation, metabolism and physiologic effects of melatonin. Adv Pharmacol 1968; 6: 141-151.
27. Venegas C, Garcia JA, Escames G, et al., Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-227.
28. Sagrillo-Fagundes L, Soliman A, Vaillancourt C,. Maternal and placental melatonin: actions and implication for successful pregnancies. Minerva Ginecol 2014; 66: 251-266.
29. Mauriz JL, Collado PS, Veneroso C, et al., A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
30. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
31. Reiter RJ, Tamura H, Tan DX, et al., Melatonin and the circadian system: contributions to successful female reproduction. Fertil Steril 2014; 102: 321-328.
32. Radogna F, Paternoster L, Albertini MC, et al., Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. J Pineal Res 2007; 43: 154-162.
33. Ekmekcioglu C,. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97-108.
34. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110.
35. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, et al., Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012; 351: 152-166.
36. Pandi-Perumal SR, Trakht I, Srinivasan V, et al., Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85: 335-353.
37. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, et al., Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 2003; 8: d1093-d1108.
38. Lanoix D, Ouellette R, Vaillancourt C,. Expression of melatoninergic receptors in human placental choriocarcinoma cell lines. Hum Reprod 2006; 21: 1981-1989.
39. Petroff MG, Phillips TA, Ka H, et al., Isolation and culture of term human trophoblast cells. Methods Mol Med 2006; 121: 203-217.
40. Lanoix D, Lacasse AA, St-Pierre J, et al., Quantitative PCR pitfalls: the case of the human placenta. Mol Biotechnol 2012; 52: 234-243.
41. Kivela A,. Serum melatonin during human pregnancy. Acta Endocrinol 1991; 124: 233-237.
42. Nakamura Y, Tamura H, Kashida S, et al., Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res 2001; 30: 29-33.
43. Tamura H, Nakamura Y, Terron MP, et al., Melatonin and pregnancy in the human. Reprod Toxicol 2008; 25: 291-303.
44. Vatish M, Steer PJ, Blanks AM, et al., Diurnal variation is lost in preterm deliveries before 28 weeks of gestation. BJOG 2010; 117: 765-767.
45. Tamura H, Nakamura Y, Korkmaz A, et al., Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 2009; 92: 328-343.
46. Glattre E, Bjerkedal T,. The 24-hour rhythmicity of birth. A populational study. Acta Obstet Gynecol Scand 1983; 62: 31-36.
47. Cagnacci A, Soldani R, Melis GB, et al., Diurnal rhythms of labor and delivery in women: modulation by parity and seasons. Am J Obstet Gynecol 1998; 178: 140-145.
48. Ducsay CA, Yellon SM,. Photoperiod regulation of uterine activity and melatonin rhythms in the pregnant rhesus macaque. Biol Reprod 1991; 44: 967-974.
49. Schlabritz-Loutsevitch N, Hellner N, Middendorf R, et al., The human myometrium as a target for melatonin. J Clin Endocrinol Metab 2003; 88: 908-913.
50. Takayama H, Nakamura Y, Tamura H, et al., Pineal gland (melatonin) affects the parturition time, but not luteal function and fetal growth, in pregnant rats. Endocr J 2003; 50: 37-43.
51. Sharkey JT, Cable C, Olcese J,. Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner. J Clin Endocrinol Metab 2010; 95: 2902-2908.
52. Sharkey JT, Puttaramu R, Word RA, et al., Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells. J Clin Endocrinol Metab 2009; 94: 421-427.
53. Reiter RJ, Rosales-Corral SA, Manchester LC, et al., Peripheral reproductive organ health and melatonin: Ready for prime time. Int J Mol Sci 2013; 14: 7231-7272.
54. Sampaio RV, Conceicao S, Miranda MS, et al., MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro. Reprod Biol Endocrinol 2012; 10: 103.
55. Sharp AN, Heazell AE, Crocker IP, et al., Placental apoptosis in health and disease. Am J Reprod Immunol 2010; 64: 159-169.
56. Lanoix D, Lacasse AA, Reiter RJ, et al., Melatonin: the smart killer: the human trophoblast as a model. Mol Cell Endocrinol 2012; 348: 1-11.
57. Sainz RM, Mayo JC, Rodriguez C, et al., Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-1426.
58. Winczyk K, Pawlikowski M, Lawnicka H, et al., Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo. Neuro Endocrinol Lett 2002; 23 (Suppl 1): 50-54.
59. Jawed S, Kim B, Ottenhof T, et al., Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Eur J Pharmacol 2007; 560: 17-22.
60. Jablonska K, Pula B, Zemla A, et al., Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J Pineal Res 2013; 54: 334-345.
61. Radio NM, Doctor JS, Witt-Enderby PA,. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 2006; 40: 332-342.
62. Orendi K, Gauster M, Moser G, et al., The choriocarcinoma cell line BeWo: syncytial fusion and expression of syncytium-specific proteins. Reproduction 2010; 140: 759-766.
63. Gudermann T, Birnbaumer M, Birnbaumer L,. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2 + mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J Biol Chem 1992; 267: 4479-4488.
64. Fujimoto A, Osuga Y, Fujiwara T, et al., Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 2002; 19: 550-554.
65. Garrido-Gomez T, Dominguez F, Simon C,. Proteomics of embryonic implantation. Handb Exp Pharmacol 2010; 67-78.
66. Cole LA,. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010; 8: 102.
67. Licht P, Fluhr H, Neuwinger J, et al., Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol 2007; 269: 85-92.
68. Cary GA, Cuttler AS, Duda KA, et al., Melatonin: neuritogenesis and neuroprotective effects in crustacean x-organ cells. Comp Biochem Physiol A Mol Integr Physiol 2012; 161: 355-360.
69. Dubocovich ML,. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246: 902-910.
70. Mathes AM, Wolf B, Rensing H,. Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro. J Pineal Res 2008; 45: 337-338.